
SciBase
Develops AI-powered point-of-care devices for early detection and prevention of skin disorders.
About
SciBase develops and commercializes Nevisense, a point-of-care platform that combines AI and advanced EIS technology to improve diagnostic accuracy in the detection of skin cancer and skin barrier alterations. This platform empowers healthcare professionals to enhance diagnostic accuracy, enable disease monitoring, and facilitate early intervention of skin cancer and skin disorders. SciBase aims to pioneer prediction and prevention in dermatology, ensuring proactive skin health management.
Key facts
At-a-glance profile data
- Website
- scibase.com
- Headquarters
- Stockholm, Sweden
- Founded
- 1998
- Total funding
- $22M (Post IPO)
- Business model
- B2B
Tech stack
Detected on scibase.com, last scanned 25 Sept 2026. Run your own scan
- Frontend
- jQuery, Bootstrap
- Backend
- PHP
- Analytics
- Google Analytics 4, Google Tag Manager
- SEO
- All in One SEO
- CMS / Builders
- WordPress
- Email provider
- Microsoft 365
- Maps
- Google Maps
Frequently asked
How much funding has SciBase raised?
SciBase has raised a total of $22M in funding. The most recent round on record is Post IPO.